Neem Bark
Neem bark from Azadirachta indica contains triterpenoids like nimbidin and nimbin that demonstrate antimicrobial activity by disrupting bacterial cell walls and inhibiting COX-2 inflammatory pathways. Clinical evidence remains limited, with most therapeutic support derived from in vitro studies and traditional Ayurvedic applications.

Origin & History
Neem Bark, from the *Azadirachta indica* tree, is native to the Indian subcontinent, including India, Bangladesh, Myanmar, and Sri Lanka. Flourishing in dry tropical and subtropical climates, this revered botanical is a cornerstone in traditional healing systems for its potent detoxifying and antimicrobial properties.
Historical & Cultural Context
Revered for millennia in South Asian cultures as the "Village Pharmacy," Neem Bark (*Azadirachta indica*) embodies protection, purification, and healing. Its extensive use in Ayurvedic, Unani, and Siddha medicine for daily rituals, herbal remedies, and spiritual practices reflects its profound cultural and ecological significance.
Health Benefits
- **Enhances immune resilience**: and combats bacterial, viral, and fungal infections through azadirachtin, nimbin, and flavonoids. - **Supports liver detoxification**: by stimulating bile production and protecting hepatocytes from oxidative damage. - **Promotes oral health**: and dental care by reducing gum inflammation and preventing plaque buildup. - **Alleviates inflammation and**: joint pain via its anti-inflammatory compounds. - **Improves cardiovascular health**: by supporting circulation and vascular integrity. - **Regulates blood sugar**: levels by enhancing insulin sensitivity and aiding metabolic balance.
How It Works
Nimbidin and nimbin disrupt microbial cell wall synthesis and membrane integrity while suppressing COX-2 enzyme activity to reduce inflammatory prostaglandin production. Phenolic compounds and flavonoids provide antioxidant protection through free radical scavenging via hydroxyl groups. These bioactive compounds also modulate immune responses by downregulating NF-κB inflammatory pathways and inhibiting nitric oxide release in activated macrophages.
Scientific Research
Research, including in vitro and animal studies, supports Neem Bark's antimicrobial, anti-inflammatory, and hepatoprotective properties. Further clinical trials are needed to fully establish its efficacy in human health, particularly for its traditional uses in detoxification and metabolic balance.
Clinical Summary
Clinical evidence for neem bark remains extremely limited, with only one small trial in HIV patients showing increased CD4+ and CD8+ cell counts following neem bark powder treatment, though specific dosages and sample sizes were not reported. Most therapeutic evidence derives from in vitro studies demonstrating antimicrobial activity against E. coli, S. aureus, P. aeruginosa, and C. albicans. Preclinical research shows NF-κB inhibition with IC50 values of 220-250 μg/ml in cell cultures, but large-scale randomized controlled trials in humans are lacking. The clinical application is significantly limited by toxicity concerns, poor bioavailability, and standardization issues.
Nutritional Profile
- Minerals: Calcium, Magnesium, Zinc - Phytochemicals: Azadirachtin, Nimbin, Nimbidin, Flavonoids, Polyphenols, Tannins, Triterpenoids, Polysaccharides
Preparation & Dosage
- Common forms: Decoctions, powders, tinctures, standardized extracts, topical applications (e.g., oral care products, skin formulations). - Dosage: 500–1000 mg standardized extract daily or 1–2 ml tincture twice daily. - Traditional application: Used for skin diseases, fevers, dental health, and detoxification.
Synergy & Pairings
Role: Bark botanical Intention: Cardio & Circulation | Immune & Inflammation Primary Pairings: - Turmeric (Curcuma longa) - Ginger (Zingiber officinale) - Ashwagandha (Withania somnifera) - Camu Camu (Myrciaria dubia)
Safety & Interactions
High doses may cause gastrointestinal upset, and clinical use is limited by potential cytotoxicity at elevated concentrations and poor bioavailability. Neem bark is contraindicated during pregnancy due to teratogenic risks from limonoid compounds like azadirachtin, and should be used cautiously in immunocompromised individuals and children due to insufficient pediatric safety data. Potential drug interactions may occur with NSAIDs or corticosteroids due to COX-2 inhibitory effects, and antioxidant properties could theoretically interfere with pro-oxidant chemotherapy agents. Long-term use should be avoided without medical monitoring due to standardization issues and toxicity concerns.